| Literature DB >> 23453040 |
Denise K Gessner1, Anja Fiesel, Erika Most, Jennifer Dinges, Gaiping Wen, Robert Ringseis, Klaus Eder.
Abstract
BACKGROUND: In pigs, enteric infections and the development of gut disorders such as diarrhoea are commonly observed, particularly after weaning. The present study investigated the hypothesis that feeding a grape seed and grape marc extract (GSGME) as a dietary supplement has the potential to suppress the inflammatory process in the small intestine of pigs by modulating the activities of NF-κB and Nrf2 due to its high content of flavonoids.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23453040 PMCID: PMC3599961 DOI: 10.1186/1751-0147-55-18
Source DB: PubMed Journal: Acta Vet Scand ISSN: 0044-605X Impact factor: 1.695
Composition of the basal experimental diets fed in phase I (body weight <15 kg) and II (body weight >15 kg)
| | | |
| Wheat | 381.7 | 406.9 |
| Barley | 315 | 302 |
| Soy bean meal (44% crude protein) | 250 | 240 |
| Soy oil | 15 | 15 |
| Mineral and vitamin premix* | 33.5 | 33.4 |
| L-Lysine | 2.6 | 1.5 |
| DL-methionine | 1.0 | 0.5 |
| L-threonine | 1.2 | 0.7 |
| Metabolisable energy (MJ/kg) † | 12.9 | 13.4 |
| Dry matter (%) ‡ | 88.7 | 89.4 |
| Crude protein (%) ‡ | 19.6 | 19.1 |
| Crude fibre (%) ‡ | 5.3 | 4.9 |
| Crude fat (%) ‡ | 3.4 | 4.4 |
| Crude ash (%) ‡ | 4.8 | 5.1 |
| Digestible lysine (%) ¥ | 1.16 | 1.05 |
| Digestible methionine + cysteine (%) ¥ | 0.62 | 0.57 |
| Digestible threonine (%) ¥ | 0.69 | 0.63 |
| Digestible tryptophan (%) ¥ | 0.21 | 0.21 |
*The mineral and vitamin premix (Bergin Novamast, Bergophor, Kulmbach, Germany) provided the following per kg diet: 1.34 g lysine, 1,020 FYT phytase, 102 mg iron, 102 mg manganese, 102 mg zinc, 20.4 mg copper, 2.21 mg iodine, 0.44 mg selenium, 13,400 IE vitamin A, 2,244 IE vitamin D3, 102 mg vitamin E (α-tocopherol acetate), 2.55 mg vitamin K, 2.55 mg vitamin B1, 6.8 mg vitamin B2, 5.1 mg vitamin B6, 34 μg vitamin B12, 34 mg nicotinic acid, 17 mg Ca-D-pantothenic acid, 1 mg folic acid, 136 μg biotin, 340 g choline chloride.
† Calculated according to recommendations of German Society for Nutrition Physiology.
‡ Analysed (mean values of three analyses per diet).
¥ calculated using tabular values from AMINODat® 4.0 (Evonik Industries AG, Essen, Germany).
Characteristics of gene-specific primers
| ATP5G1 | CAGTCACCTTGAGCCGGGCGA | 94 | NM_001025218.1 |
| TAGCGCCCCGGTGGTTTGC | |||
| ACTB | GACATCCGCAAGCACCTCTA | 205 | NM_001167795 |
| ACATCTGCTGGAAGGTGGAC | |||
| GAPDH | AGGGGCTCTCCAGAACATCATCC | 446 | AF017079.1 |
| TCGCGTGCTCTTGCTGGGGTTGG | |||
| GPI | CACGAGCACCGCTCTGACCT | 365 | NM_214330.1 |
| CCACTCCGGACACGCTTGCA | |||
| RPS9 | GTCGCAAGACTTATGTGACC | 327 | CAA23101 |
| AGCTTAAAGACCTGGGTCTG | |||
| SDHA | CTACGCCCCCGTCGCAAAGG | 380 | DQ402993 |
| AGTTTGCCCCCAGGCGGTTG | |||
| CCL2 | GGTCCTTGCCCAGCCAGATGC | 170 | NM_214214.1 |
| CTGCACAGATCTCCTTGCCCGC | |||
| CYP1A1 | CTGCCATCTTCTGCCTTGTA | 314 | NM_214412.1 |
| GCTCTGGCCATTAGAGATCA | |||
| GPX1 | CTTCGAGAAGTTCCTGGTGG | 232 | NM_214201.1 |
| CCTGGACATCAGGTGTTCCT | |||
| HMOX1 | AGCTGTTTCTGAGCCTCCAA | 130 | NM_001004027.1 |
| CAAGACGGAAACACGAGACA | |||
| HP | GTTCGCTATCACTGCCAAAC | 108 | NM_214000.1 |
| CAGTTTCTCTCCAGTGACCT | |||
| ICAM1 | CGGTGGCAGCCGTGGCTATC | 208 | NM_213816.1 |
| TTGATGCAGCCCCGCTCGTC | |||
| IL1B | GTTCTCTGAGAAATGGGAGC | 143 | NM_214055.1 |
| CTGGTCATCATCACAGAAGG | |||
| IL8 | ACTTCCAAACTGGCTGTTGC | 120 | NM_213867.1 |
| GGAATGCGTATTTATGCACTGG | |||
| IL6 | AGCAAGGAGGTACTGGCAGA | 257 | NM_001252429.1 |
| GTGGTGGCTTTGTCTGGATT | |||
| NQO1 | CCAGCAGCCCGGCCAATCTG | 160 | NM_001159613.1 |
| AGGTCCGACACGGCGACCTC | |||
| PRDX6 | GGCCGCATCCGTTTCCACGA | 280 | NM_214408.1 |
| ACTGGATGGCAAGGTCCCGACT | |||
| SOD1 | TCCATGTCCATCAGTTTGGA | 250 | NM_001190422.1 |
| CTGCCCAAGTCATCTGGTTT | |||
| SAA | GGCATCATTCCTCAAGGAAG | 168 | NM_001044552.1 |
| CTGATCACTTTAGCAGCCCA | |||
| TNFα | CATGAGCACTGAGAGCATGA | 170 | NM_214022.1 |
| CGATAACTTCGAAGTGCAGT | |||
| TXNRD1 | CTTTACCTTATTGCCCGGGT | 162 | NM_214154.2 |
| GTTCACCGATTTTGTTGGCC | |||
Average expression stability ranking of six candidate reference genes used in liver and duodenal mucosa tissue to their stability score M
| | ||||
|---|---|---|---|---|
| ATP5G1 | 0.059 | SDHA | 0.066 | |
| | RPS9 | 0.057 | GAPDH | 0.070 |
| | SDHA | 0.062 | GPI | 0.077 |
| | ACTB | 0.068 | ATP5G1 | 0.078 |
| | GPI | 0.074 | ACTB | 0.086 |
| GAPDH | 0.110 | RPS9 | 0.102 | |
* calculated by the Microsoft Excel-based application GeNorm.
Growth performance parameters of pigs fed a control diet or a diet supplemented with 1% GSGME
| Initial body weight (kg) | 11.7 ± 0.4 | 11.5 ± 0.5 |
| Final body weight (kg) | 30.7 ± 2.1 | 31.9 ± 1.9 |
| Daily feed intake (g) | 1090 ± 100 | 1113 ± 82 |
| Daily body weight gain (g) | 681 ± 75 | 726 ± 62 |
| Gain:feed ratio (g gain/kg feed) | 624 ± 24 | 652 ± 29 |
Results are shown as mean ± SD (n = 12/group). *Means are significantly different, P < 0.05.
Concentrations of α-tocopherol, TBARS and antioxidative capacity in pigs fed a control diet or a diet supplemented with 1% GSGME
| | | |
| Liver, nmol/g | 26 ± 9 | 29 ± 9 |
| Plasma, nmol/g | 0.83 ± 0.27 | 0.95 ± 0.20 |
| Plasma, mmol/mol lipid# | 0.33 ± 0.06 | 0.34 ± 0.05 |
| | | |
| Liver, nmol/g liver | 30 ± 10 | 28 ± 2 |
| Plasma, μmol/L | 5.7 ± 1.3 | 5.8 ± 1.3 |
| Plasma, mmol/mol lipids# | 1.9 ± 0.4 | 1.9 ± 0.3 |
| | | |
| Plasma, mM Trolox equivalents | 319 ± 31 | 307 ± 39 |
Results are shown as mean ± SD (n = 12/group). #Sum of triglycerides and cholesterol.
Figure 1Relative DNA-binding activity of NF-κB in the nuclear extract of duodenal mucosa of pigs fed the control diet or GSGME containing diet. Nuclear extract from Jurkat cells without stimulation was used as negative control (Jurkat -) and nuclear extract from Jurkat cells with NF-κB stimulation were used as positive control (Jurkat +). Bars represent mean ± SD of 12 pigs per group and are expressed as fold of NF-κB DNA-binding activity of the control group. *Significantly different from the control group; P < 0.05.
Figure 2Relative mRNA abundance of NF-κB target genes ICAM1, CCL2, TNFα, IL8, IL6, IL1B, SAA and HP in the duodenal mucosa of pigs fed the control diet or GSGME containing diet. Bars represent mean ± SD of 12 pigs per group and are expressed as fold of relative mRNA abundance of the control group. *Significantly different from the control group; P < 0.05.
Figure 3Relative DNA-binding activity of Nrf2 in the nuclear extract of duodenal mucosa of pigs fed the control diet or GSGME containing diet. Nuclear extract from unstimulated COS-7 cells was used as negative control (COS-7 -) and nuclear extract from Nrf2 transfected COS-7 cells was used as positive control (COS-7 +). Bars represent mean ± SD of 12 pigs per group and are expressed as fold of Nrf2 DNA-binding activity of the control group. *Significantly different from the control group; P < 0.05.
Figure 4Relative mRNA abundance of Nrf2 target genes GPX1, NQO1, PRDX6, SOD1, TXNRD1, CYP1A1 and HMOX1 in the duodenal mucosa of pigs fed the control diet or GSGME containing diet. Bars represent mean ± SD of 12 pigs per group and are expressed as fold of relative mRNA abundance of the control group. *Significantly different from the control group; P < 0.05.